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Summary
Our previous studies have demonstrated that mice with reduced or absent serotonin transporter
(SERT+/− and SERT−/− mice, respectively) are more sensitive to stress relative to their SERT normal
littermates (SERT+/+ mice). The aim of the present study was to test the hypothesis that the
hypothalamic-pituitary-adrenal (HPA) axis and its feedback regulation are impaired in these mice.
The function and gene expression of several components in the HPA axis and its feedback regulation
in SERT+/+, +/− and −/− mice were studied under basal (non-stressed) and stressed conditions. The
results showed that 1) under basal conditions, corticotrophin-releasing factor (CRF) mRNA levels
in the paraventricular nucleus (PVN) of the hypothalamus was lower in both SERT+/− and −/− mice
relative to SERT+/+ mice; 2) an increased response to CRF challenge was found in SERT−/− mice,
suggesting that the function of CRF type 1 receptors (CRF R1) in the pituitary is increased. Consistent
with these findings, 125I-sauvagine (a CRF receptor antagonist) binding revealed an increased density
of CRF R1 in the pituitary of SERT −/− under basal conditions. These data suggest that CRF R1 in
the pituitary of SERT−/− mice is up-regulated. However, in the pituitary of SERT+/−mice, the
function of CRF R1 was not changed and the density of CRF R1 was reduced relative to SERT+/+
mice; and 3). The expression of the glucocorticoid receptor (GR) in the hypothalamus, pituitary and
adrenal cortex was significantly reduced in SERT+/−and −/− mice in comparison with SERT+/+
mice under basal conditions. Consistent with these findings, the corticosterone response to
dexamethasone was blunted in SERT−/−mice relative to SERT+/+ and +/− mice. Furthermore, stress
induces a rapid increase of the GR expression in the hypothalamus of SERT +/− and −/− mice relative
to their basal levels. Together, the present results demonstrated that the HPA axis and its feedback
regulation are altered in SERT knockout mice, which could account for the increased sensitivity to
stress in these mice.
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The serotonin (5-HT) transporter (SERT, 5-HTT) functions as a 5-HT reuptake site to take
extracellular 5-HT back into the nerve terminals, resulting in termination of 5-HT receptor
stimulation. Thus, the function of SERT is critical to control 5-HT activity, which plays an
important role in regulation of emotions. SERT is not only a target for selective serotonin
reuptake inhibitors (SSRIs), the most widely used antidepressants, but also may be a genetic
component for the pathogenesis of affective disorders. Several polymorphisms and mutations
have been found in the SERT promoter and coding regions (Murphy et al. 2004), such as a
polymorphism in the 5-HT transporter-linked promoter region (5-HTTLPR) (Hu et al. 2005;
Nakamura et al. 2000; Lesch et al. 1996; Hu et al. 2006). Studies have demonstrated that
individuals carrying lower SERT expression genotypes are more sensitive to stress. Several
recent studies revealed that the number of stressful life events correlates to the severity and
number of episodes of major depression in the individuals carrying lower SERT expression
genotypes (Caspi et al. 2003; Zalsman et al. 2006; Roy et al. 2007). These data raise the question
as to why individuals with lower SERT expression genotypes are more vulnerable to stressful
events. A recent study reported that psychological stress, such as public speech, significantly
increases plasma ACTH and cortisol levels in the individuals with lower SERT expression
genotypes (Jabbi et al. 2007). These data suggest that the sensitivity of HPA axis response to
stress is increased in the individuals with lower SERT expression genotypes. Since increased
activity of HPA axis is known to be involved in the pathophysiology of affective disorders,
the increased sensitivity of HPA axis response to stress could be a trigger for the development
of affective disorders in these individuals when they suffer stressful events. Therefore, studying
the mechanisms by which the reduction in SERT function during development influences the
sensitivity of HPA axis response to stress will provide significant insight for our understanding
the etiology of affective disorders and thus, may lead to develop better approaches to prevent
and treat affective disorders.
SERT knockout mice were generated by homologous recombination that replaced the second
exon of SERT with a neo-cassette (Bengel et al. 1998). In these mice, SERT is constitutively
absent (SERT−/−) or reduced (SERT +/−). In several aspects, the SERT knockout mice,
especially SERT+/− mice, are similar to humans with lower SERT expression genotypes (Li
2006; Kalueff et al. 2007; Murphy and Lesch 2008). For example, both SERT (+/−) and humans
with lower SERT expression genotypes have about a 50% reduction in SERT expression during
early development relative to the SERT+/+ mice and individuals with high expression genotype
of 5-HTTLPR, respectively. In addition, the SERT uptake rate is slightly reduced in both SERT
+/− (vs. SERT+/+) mice and individuals with lower expression genotype of 5-HTTLPR (vs.
high expression genotype) (Greenberg et al. 1999). Behavioral studies reveal that the SERT
knockout mice are more anxious compared to SERT+/+ mice (Holmes et al. 2003d).
Furthermore, SERT knockout mice (both SERT +/− and −/− mice) are more sensitive to stress.
Mild stress, such as handling and saline injection, significantly increases ACTH secretion in
SERT+/− and −/− mice (Li et al. 1999). These data suggest that disruption of SERT function
early in life may alter the development of the HPA axis, resulting in increased sensitivity to
stress.
To test the hypothesis that the HPA axis and its feedback regulation are altered in SERT
knockout mice, in the present study, we characterized the components of the HPA axis and its
feedback regulation in SERT knockout mice. The HPA axis is a major system responsible for
maintaining homeostasis in response to stress. Corticotrophin-releasing factor (CRF) in the
paraventricular nucleus (PVN) of the hypothalamus is the initial point of the HPA axis-stress
system. Stress activates the CRF neurons through activation of numerous neurotransmitters
and consequently increases the CRF secretion through the medial eminence to the anterior
pituitary. The CRF then activates CRF type 1 receptors (CRF R1) in the anterior pituitary and
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stimulates ACTH release into the circulation. The ACTH activates the secretor cells in the zona
fasciculata of the adrenal cortex to release glucocorticoid, corticosterone (in rodent) or cortisol
(in human). The glucocorticoids trigger gene transcription and alter protein synthesis through
activation of mineralocorticoid (MR) and glucocorticoid receptors (GR). Activation of MR
and GR also produces a negative feedback regulation for the HPA axis, which serves as a major
control of the HPA axis. GR is expressed in the hypothalamus, pituitary, adrenal cortex and
also in the hippocampus, as an upstream control of the HPA axis. On the other hand, MR is
mainly expressed in the hippocampus and is responsible for controlling physiological and mild
stress-related variation of the HPA axis (Pace and Spencer 2005). In the present study, the
function and expression of components of the HPA axis, such as CRF and CRF R1, and its
feedback regulation, such as GR, were examined in the hypothalamus, pituitary and adrenal
gland of SERT+/+, +/− and −/− mice under basal (non-stressed) and stressed conditions.
Methods
Animals
SERT knockout mice were purchased from Taconic Farm Inc. (Hudson, NY) and bred in the
University of Texas Medical Branch animal facility. In SERT knockout mice, the second exon
of the SERT gene was replaced by a neo-cassette (Bengel et al. 1998). The mice were
backcrossed on a congenital C57/BL6 genetic background for 14 generations. SERT+/− mice
were used for mating to minimize potential effects of differences in maternal care behaviors.
The genotypes of the mice were identified using a PCR procedure. Mouse genomic DNA was
extracted from tail tissue (Bengel et al. 1998). The PCR was conducted with 1X PCR buffer,
1.5 mM MgCl2, 0.2 mM each of dATP, dTTP, dGTP, 0.1mM dCTP and 0.1mM 7-dezae-dCTP
(GE Amersham, Piscataway, NJ), 0.5 μM each primers and premium Taq polymerase
(Invitrogen, Carlsbad, CA) at 95°C for 5 min, 35 cycles of 94°C for 30 sec, 60°C for 30 sec
and 72°C for 2 min, and 72°C for 10 min. Two primers used in the PCR were upstream exon
2 primer (encoding 3′end of intron 1): 5′-TCACGGCTGCAGTGATAAGT-3′ and downstream
primer (encoding 672-652 bp of exon 2): 5′-TGCTGACTGGAGATCAGGC-3′. The wild type
of SERT produced a 1.4 kb band, while SERT knockout presented a 2 kb size band.
Male mice were used in the studies. They were two to five months of age, with body weights
of 20–25 g. The mice were housed in groups of four to five per cage in a light-(12 hour light/
dark cycle, lights on at 6 a.m.), humidity- and temperature-controlled room. Food and water
were available ad lib. All animal procedures were approved by the Institutional Animal Care
and Use Committee at the University of Texas Medical Branch.
Procedure for animal studies
Characterization of HPA axis and its feedback regulation in SERT knockout mice
under non-stressed and stressed conditions—Each genotype of SERT+/+, +/− and
−/−mice was randomly divided into non-stressed and stressed subgroups. To avoid unexpected
stress, two days before the experiment, mice were moved to a behavior room with an elevated
plus maze (EPM) apparatus. The mice were housed two per cage; one mouse in a non-stressed
group and the other one in a stressed group were housed in the same cage. During the
experiment, mice in the stressed group underwent stress by placement on an elevated plus
maze, while the non-stressed cage-mate was immediately decapitated in an adjacent room. The
elevated plus maze was conducted as previously described by Holmes at al (Holmes et al.
2000; Holmes et al. 2003a). Briefly, mice were individually placed on the center square of the
EPM facing an open arm and allowed to freely explore the apparatus for 5 min. Then, the mice
were decapitated immediately after the EPM exposure in an adjacent room. The brain, pituitary
and adrenal gland were collected. To determine GR levels in the hypothalamus using an
immunoblot assay, the hypothalamus were dissected and then, homogenized immediately to
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isolate non-nuclear (cytosol and membrane) and nuclear fractions, as described below. The
brains used for autoradiography were frozen immediately with dry ice-cold 2-methylbutane
followed by dry ice. The pituitaries and adrenal glands were frozen on dry ice. The brain,
pituitary and adrenal gland were wrapped with plastic wrap, parafilm and aluminum foil and
stored in −80°C until use.
Systemic CRF challenge test for the function of peripheral CRF R1—Male mice
(SERT+/+, +/− and −/−, n=5–7) were injected with saline or CRF (human and rat (h/rCRF),
20 μg/kg, 5ml/kg, sc, Sigma, St. Louis, MO). 30 min after the injection, the mice were
decapitated and the trunk blood was collected for plasma ACTH and corticosterone assays.
The determinations of the dose of CRF and the time point for decapitation were based on the
results from our preliminary study (data not shown).
Systemic dexamethasone challenge test to determine the function of GR in the
peripheral tissue—Two experiments were conducted. To establish the optimal time point
of the dexamethasone treatment, the time course of the effect of dexamethasone on ACTH and
corticosterone secretion was first examined. Male C57/B6 mice were injected with saline or
dexamethasone (water soluble, 20 μg/5ml/kg, ip, Sigma, St. Louis, MO) at 9:00 am. The mice
were decapitated 1, 2, 4 and 6 hours after the dexamethasone injection or 2 and 6 hours after
the saline injection. The trunk blood was collected for the plasma ACTH and corticosterone
concentrations.
To determine the dexamethasone response in SERT knockout mice, mice (SERT+/+, +/− and
−/−, n=6–8) were injected with dexamethasone (20 μg/5ml/kg, ip) or saline. Two hours after
the injection, mice were decapitated and plasma was collected for a corticosterone assay. We
chose the 2-hour time point because it was approximately the t1/2 for the dexamethasone-
induced suppression of corticosterone as determined by the time course above (see results and
Fig. 8). This time point is more sensitive for detection of the alterations in response to
dexamethasone.
Quantitative reverse transcription PCR for CRF mRNA in the hypothalamus
To determine the level of CRF mRNA in the hypothalamus of SERT knockout mice, the
hypothalamus of SERT +/+, +/− and −/− mice were dissected and rapidly frozen in liquid
nitrogen. The total RNA was extracted from the hypothalamus using Tri-Reagent (Sigma, St.
Louis, MO) following the manufacturer’s protocol. Briefly, the hypothalamus was
homogenized in 0.3 ml Tri-Reagent by a homogenizer at speed scale 4 and 4°C for 10 seconds.
After centrifugation, the supernatant was mixed with chloroform and the top phase was
collected after centrifugation at 16,000 g for 5 min. The RNA extract was then mixed with an
equal volume of isopropanol and centrifuged at 16,000 g for 5 min. The pellet was washed
with 75% ethanol and dissolved in 50 μl define DEPC-treated H2O after the pellet was dried
briefly.
The total RNA from the hypothalamus was treated with DNase I (Invitrogen, Carlsbad, CA)
before conducting the reverse transcription (RT) with superscript reverse transcriptase
(Invitrogen, Carlsbad, CA). Briefly, 1 μg DNase I treated RNA was mixed with 1 μl oligo d
(T)20 and 2 μl 10mM dNTP and incubated at 65°C for 5 min. Then 4 μl 5x supertranscript RT
buffer, 2 μl 0.1M DTT, 1 μl RNaseOut and 1ml superscript II RT were added into the mixture
(for a total volume of 20 μl). The RT reaction then carried out at 42°C for 50min followed by
15 min incubation at 75°C. To degrade the RNA, 1 μl RNase H (2 units) was then added and
incubated at 37°C for 20 min. The cDNA solution was stored at −20°C until use for the
quantitative PCR.
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The level of hypothalamic CRF mRNA was examined by using SYBR green real-time
polymerase chain reaction (RT-PCR) with 7500 fast Real-Time PCR system (Applied
Biosystems, Foster City, CA). In total volume of 20 μl, 2 μl of cDNA solution, 10 μl of SYBR
green PCR Master mix (Applied Biosystems, Foster City, CA ) and 200 nM of each primers
was used for each RT-PCR reaction in a 96 well plate. According to manufacturer’s suggested
conditions, the real-time PCR was conducted at 50°C for 2 min, 95°C for 10 min to activate
Taq polymerase and 50 cycles of 95°C for 0.15 min and 60°C for 1 min. An 83 bp fragment
of CRF mRNA was amplified with a forward primer (5′-CACCTACCAAGGGAGGAGAA-3′,
143–162 bp in Accession NM_205769) that is located in the exon I of CRF gene, and a reverse
primer (5′-CAGAGCCACCAGCAGCAT-3′, 225-208 bp in Accession NM_205769) that is
located in the exon II of the CRF gene. To normalize the cDNA concentration in each sample,
a RT-PCR for TATA box binding protein mRNA, i.e., a housekeeping gene, was conduced in
parallel with the CRF mRNA. The sequences of TBP primers (Forward: 5′-
GGCCTCTCAGAAGCATCACTA, Reverse: 5′-GCCAAGCCCTGAGCATAA) were
obtained from RTPrimerDB (Pattyn et al. 2006; Pattyn et al. 2003). The reason for using TBP
for normalization is that the TBP mRNA level is comparable to CRF mRNA levels in the brain
(Vandesompele et al. 2002). The relative levels of CRF mRNA were calculated using
comparative CT (ΔΔCT) method by 7500 fast SDS software in the Applied Biosystems 7500
RT-PCR systems. The TBP mRNA was used as a normalizer and a sample in SERT+/+ group
with medial value of ΔCT was used as a calibrator. The mean of the CT from three real-time
PCR reactions for each sample was used for the calculation. The RT-PCR for CRF mRNA is
linear within a three-log range of RNA concentrations. The coefficient variation of the real-
time PCR is < 1%.
Autoradiography of receptor binding and In situ hybridization
Tissue preparation—Frozen brain, pituitary and adrenal gland were cut into 15 μm-thick
coronal sections using a cryostat. Sections containing the hypothalamus [Bregma (−0.7) –
(−1.0) mm] (Paxinos and Franklin 2001) were thaw-mounted on the slides and stored at −80°
C until use. Pituitaries or adrenal glands from each group of mice were embed in one cryostat
chuck and sectioned together, so that each section contained pituitary or adrenal gland slices
of all the animals in the group. To limit the variation between the slides, each slide contained
the brain sections from three mice (one per each genotype) or the pituitary and adrenal gland
sections from the three groups (one per each genotype).
125I-sauvagine binding for the density of CRF type1 receptors in the pituitary—
Autoradiography of 125I-sauvagine binding for the density of CRF R1 in the pituitary was
conducted as described by Rominger et al with slight modification (Rominger et al. 1998).
Briefly, pituitary sections were pre-incubated in pre-assay buffer (50 mM Tris-HCI, pH 7.4,
containing 2 mM EDTA, 10 mM MgCl2) for 30 min at room temperature. Then, the slides
were incubated with 20 pM 125I-sauvagine (2200 Ci/mmonl, Perkin Elmer, MA) in assay buffer
(50 mM Tris-HCI, pH 7.4, containing 2 mM EDTA, 10 mM MgCl2, 0.1% BSA and 0.25 TIU/
ml aprotinin) for 2 hours at room temperature, in the presence of 20 nM antisauvagine-30 (a
CRF R2 antagonist) to block CRF type2 receptors. Non-specific binding was defined by 1μM
NBI 27914 (a CRF R1 antagonist, Sigma, St Louis, MO). The slides were washed 2 × 20min
in 50 mM Tris-HCl (pH 7.4) buffer at 4°C, rapidly rinsed with ice-cold ddH2O and dried. The
slides were exposed on Kodak Biomax MR film at −80°C for 10 days. A set of 125I microscales
(Amersham, IL) was exposed with the slides for calibration of the optic density into nCi/mg
tissue equivalent. The autoradiography of 125I-sauvagine binding was analyzed using the
MCID program (Research Image Inc. Ontario, Canada). Specific binding sites for each group
of animals were calculated by subtracting the mean of non-specific binding sections from the
mean of total binding sections in the group (S/N≥3).
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In situ hybridization for mRNAs of CRF, CRF R1, and GR—The in situ hybridization
procedures were carried out as previously described (Li et al. 2000). To generate probes, a
cDNA fragment was amplified using PCR with specific primers as listed in Table 1. The PCR
product was subcloned into a TOPO pCR II vector (Invetrogen, Carlsbad, CA). The generation
of 35S-UTP labeled ribo-probes and in situ hybridization were conduced as previously
described (Li et al. 2000). The autoradiography of in situ hybridization was analyzed using the
MCID program (Research Image Inc. Ontario, Canada). The mRNA level in each group of
mice was calculated by subtracting the mean of sense binding from the mean of antisense
binding.
Radioimmunoassay (RIA) for ACTH and corticosterone
RIAs for plasma ACTH and corticosterone were performed as previously described (Li et al.
1999). With the exception of the dexamethasone challenge test, 20 μl and 3 μl plasma were
used for ACTH and corticosterone assays, respectively. In the dexamethasone challenge study,
due to the reduction of hormone concentrations by dexamethasone treatment, 50 μl and 15 μl
plasma were used in ACTH and corticosterone assays, respectively.
Immunoblot for GR in the nuclear and non-nuclear fraction of the hypothalamus
The nuclear and non-nuclear (cytosol and membrane) extractions of the hypothalamus were
prepared according to the manufacturer’s instructions for a nuclear extraction kit (Active motif
Inc., Carlsbad, CA). Briefly, the hypothalamus was homogenized in 0.1 ml hypotonic buffer
with a plastic pestle. After incubation in ice for 15 min and then centrifugation at 850 x g, 4°
C for 10 min, the supernatant (cytosol) was collected and the pellet was resuspended in 0.1 ml
hypotonic buffer. After incubating at 4°C for 15 min, 5 μl detergent was added to each vial
and then vortexed for 10 sec at the highest setting. After centrifugation at 14,000 x g, 4°C for
30 sec, the supernatant (containing membrane proteins) was collected and combined with the
previous supernatant (as non-nuclear extract). The pellet (nuclei) was then resuspended into
50 μl complete lysis buffer and incubated, vortexed and centrifuged as recommended by the
manufacture’s instruction. The supernatant was collected as nuclear extract. Both extracts were
aliquotted and stored at −80°C freezer until use. The protein concentrations of the extractions
were measured using a BCA protein assay kit (Pierce biotechnology Inc. Rockford, IL)
The GR levels in the nuclear and non-nuclear extraction of the hypothalamus (GR) were
measured by using immunoblot as previously described with minor modification (Li et al.
2000). Briefly, after the proteins in the nuclear and non-nuclear extractions (~25μg protein/
lane) were resolved by SDS polyacrylamide gel electrophoresis and the proteins were
transferred to a polyvinylidene difluoride (PVDF) membrane, they were incubated with GR
(1:200 dilution) monoclonal antibody (Affinity BioReagent Inc, Golden, CO) at 4°C overnight.
After washes, the membranes were incubated with alkaline phosphatase-conjugated goat anti-
mouse IgG antibody (1:10,000, Tropix, Bedford, MA) and reacted with chemiluminescence
substrate solution, CDP-Star subtract (Tropix, Bedford, MA) as previously described (Li et al.
2000). The chemiluminescent bands in the membranes were captured by a Chemidoc XRS
image system (Bio-Rad, Richmond, CA) and the density of the bands was analyzed using an
image analysis program (Quantity One, Bio-Rad, Richmond, CA). Each blot contained 2–4
samples from each group of mice (SERT+/+, +/− and −/− mice with or without stress).
The samples were randomly arranged in the blot. The relative GR concentration of each sample
was calculated as percent of the mean density of the samples from non-stressed SERT+/+ mice
in the same blot. The data point for each mouse sample was the mean of the values on
determined from three separate blots.
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The data were presented as mean ± SEM of 5–7 mice for autoradiographic and immunoblot
studies and 8–10 mice for RIAs, unless mentioned in the experimental design section. The data
were analyzed by two-way analysis of variance (ANOVA). In order to compare the difference
between groups, a one way ANOVA was conduced followed by a Student Newman-Keuls
post-hoc test. In the dexamethasone test, due to the time points differences between saline and
dexamethasone treatments, a one-way ANOVA followed by a Student-Newman-Keuls post-
hoc test was used to compare the difference among the time points within each treatment. A t-
test was used for comparing the difference between saline and dexamethasone treatments 2
hours after the injection. All of the statistical analysis was conducted using StatView software
(Abacus Concepts Inc, Berkeley, CA).
Results
Characterization of the HPA axis in SERT knockout mice
Alterations in CRF mRNA in the PVN—Using in situ hybridization, we detected high
density of CRF mRNA in the PVN of of mice (Fig. 1A). The CRF mRNA level in the PVN of
SERT+/− and −/− mice was significantly reduced in comparison to SERT +/+ mice under non-
stressed (basal) conditions (Fig. 1B; One-Way ANOVA: F(2,8)=14.57, P<0.01). The reductions
of CRF mRNA in SERT +/− and −/− were 30% and 43%, respectively. To confirm the results,
we further conduced a quantitative RT-PCR in the hypothalamus of SERT +/− and −/− mice.
Consistently, the results from the real-time RT-PCR reveal that the CRF mRNA levels were
reduced in the hypothalamus of SERT +/− and −/− mice (Figure 1C; 47% and 49% reduction
for SERT +/− and −/− mice, respectively. One-Way ANOVA: F(2, 9) = 5.78, P = 0.024).
Alterations in CRF R1 receptors in the pituitary—To determine the function of CRF
R1 in SERT knockout mice, a systemic CRF challenge study was conducted. Consistent with
our previous observations, saline injection significantly increased plasma ACTH concentration
in both SERT+/− and −/−mice (Fig. 2 top panel), suggesting an increased sensitivity to stress.
ACTH responses to CRF were increased in a genotype-dependent manner in SERT knockout
mice. The CRF-induced increase in ACTH secretion was significantly higher in SERT−/− mice
than that in SERT+/+mice (Fig. 2 top panel, Two-way ANOVA: main effect of genotype,
F(2, 27) = 5.98, P = 0.01; main effect of CRF, F(1, 27) = 40.58, P < 0.001; and interaction between
genotype and CRF, F(2, 27) = 1.39, P = 0.27). An increased corticosterone concentration was
observed in SERT−/− mice 30 min after saline injection (Fig 2 bottom panel). Administration
of CRF increased plasma corticosterone concentrations in SERT +/+ and +/− mice, but did not
further increase corticosterone levels in SERT −/− mice. The CRF-induced increase of
corticosterone concentration was not significantly different among three genotypes of the mice
(Fig. 2 bottom panel, Two-way ANOVA: main effect of genotype, F(2, 33) = 9.01, P<0.001;
main effect of CRF, F(1, 33) = 26.5, P<0.001; and interaction between genotype and CRF,
F(2, 33) = 5.39, P < 0.01).
To determine whether the increased ACTH response to CRF is due to an increase in the binding
sites of CRF R1, the density of CRF R1 in the pituitary was examined using 125I-sauvagine
binding. As shown in fig. 3, the density of CRF R1 in the pituitary was differentially altered
in SERT +/− and −/− mice. Under non-stressed conditions, the density of CRF R1 was reduced
in SERT+/− mice, but increased in SERT−/− mice relative to SERT+/+ mice. Stress with EPM
for 5 min significantly increased the density of CRF R1 in the pituitary of all three genotypes
of mice (Fig. 3B, Two-way ANOVA: main effect of genotype, F(2, 133) = 26.808, P<0.001;
main effect of stress, F(1,133) = 37.044, P<0.001; and interaction between genotype and stress,
F(2, 133) = 0.214, P=0.807).
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To determine whether the changes in the binding sites of CRF R1 are due to alterations in the
expression of CRF R1, the CRF R1 mRNA in the pituitary of SERT knockout mice was
examined by in situ hybridization. As shown in Fig 4A, although there is visible binding of
the sense probe (non-specific binding), the density of the antisense probe binding was
significantly higher than that of sense probe (S/N ≈ 2; 78 ±1.9 (antisense) vs. 39 ±1.2 (sense)
nCi/g tissue in non-stressed SERT+/+ mice). Therefore, the difference between the antisense
and sense is sufficient to represent the specific binding for CRF R1 mRNA. Although a trend
of genotype-dependent reduction in CRF R1 mRNA levels was observed in the pituitary, there
were no statistically significant differences among SERT +/+, +/− and −/− mice under non-
stressed conditions. Stress with EPM for 5 min did not alter CRF R1 mRNA in the pituitary
of SERT+/+ and −/− mice, but significantly decreased CRF R1 mRNA in SERT+/− mice. The
CRF R1 mRNA in both SERT+/− and −/− mice were significantly lower than SERT +/+ mice
under stressed conditions (Fig. 4B, Two-way ANOVA: main effect of genotype, F(2, 62) =7.92,
P<0.001; main effect of stress, F(1, 62) =10.351, P< 0.05; and interaction between genotype and
stress, F(2, 62) = 0.66, P = 0.52).
Alterations in the feedback regulation of the HPA axis
The activity of the HPA axis is controlled by glucocorticoid receptors (GR). GRs are nuclear
receptors. Before binding to ligand, the Grs are located in the cytoplasm. When activated by
corticosterone, these receptors move to the nucleus and alter the gene transcription. Therefore,
the amount of GR in the cytoplasm represents the basal level of the receptors, whereas the GR
in the nucleus indicate the activated receptors. In order to distinguish the basal and activated
receptors, we examined the GR in the nuclear and non-nuclear fractions of the hypothalamic
extracts.
GR in the hypothalamus—As shown in Fig. 5A, the GR monoclonal antibody detected a
~90 Kd band in both fractions of the hypothalamus. Under non-stressed conditions, the GR
levels in both non-nuclear and nuclear fractions of the hypothalamus were significantly lower
in SERT+/− and −/− mice than that in SERT+/+ mice (Fig. 5B). The nuclear GR level in the
hypothalamus of SERT+/− mice was increased to normal levels after stress with EPM for 5
min. This stress-induced increase in GR level was not observed in SERT−/− mice (Two-way
ANOVA for non-nuclear fraction: main effect of genotype, F(2, 24) = 12.75, P<0.001; main
effect of stress, F(1, 24) = 3.45, P = 0.076; and interaction between genotype and stress,
F(2, 24) = 0.396, P = 0.676. Two-way ANOVA for nuclear fraction: main effect of genotype,
F(2, 26) = 10.212, P<0.001; main effect of stress, F(1, 26) = 13.595, P < 0.05; and interaction
between genotype and stress, F(2, 26) = 6.403, P<0.05).
GR mRNA in the hypothalamus—To determine whether the changes in the GR protein
level are due to the alterations in expression of GR, GR mRNA levels in the hypothalamus
were examined using in situ hybridization. As shown in Fig 6A, high levels of GR mRNA were
detected in the PVN. In comparison to SERT+/+ mice, GR mRNA in the PVN of the
hypothalamus is reduced in the SERT+/− and −/− mice under non-stressed conditions (Fig.
6B). Stress for 5 min did not significantly alter the levels of GR mRNA in the PVN of any
genotype of the mice relative to those under the non-stressed conditions (Fig. 6B). Two-way
ANOVA for the GR mRNA in the PVN: main effect of genotype, F(2, 24) = 10.9, P<0.001;
main effect of stress, F(1, 24) = 3.1, P = 0.09; and interaction between genotype and stress,
F(2, 24) = 1.1, P=0.33.
GR mRNA in the pituitary and adrenal cortex—To determine whether GR expression
was altered in the pituitary and adrenal cortex, GR mRNA levels were determined using in
situ hybridization. The GR mRNA was distributed in the anterior pituitary and adrenal cortex
(Fig. 7A). In comparison to the pituitary, a relatively high sense probe binding (non-specific
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binding) was observed in the adrenal gland. Since the concentration of the probe and other
assay conditions were identical for both tissues, the high non-specific binding in the adrenal
cortex may be due to different tissue structures between the pituitary and adrenal cortex.
However, the density of antisense probe binding was significantly higher than that of sense
probe. The signal to noise ratio is about 2 in non-stressed SERT+/+ mice (324.8 ± 20.7 vs 154.6
± 10.3). Therefore, the difference between the antisense and sense is sufficient to represent the
specific binding for CRF R1 mRNA.
Under non-stressed conditions, the GR mRNA levels were significantly reduced in the pituitary
of SERT+/− and −/− mice relative to SERT+/+ mice. Stress with EPM for 5 min significantly
reduced pituitary GR mRNA in SERT+/+ mice (Fig 7B). Although there was a slight but
significant reduction of GR mRNA in SERT−/− mice after stress, the stress-induced reduction
of GR mRNA was not observed in SERT+/− mice (two-way ANOVA: main effect of genotype,
F(2, 137) = 2.027, P = 0.136; main effect of stress, F(1, 137) = 21.47, P<0.001; and interaction
between genotype and stress, F(2, 137) = 14.113, P < 0.001).
In the non-stressed mice, the GR mRNA levels in the adrenal cortex were significantly reduced
in SERT +/− and −/− mice relative to SERT+/+ mice (Fig. 7C). The reduction was in a
genotype-dependent manner. The level of GR mRNA in the SERT−/−mice was only about one
fourth of that in SERT+/+ mice. Stress with EPM for 5 min significantly reduced GR mRNA
in SERT+/+ and +/− mice, but not in SERT−/− mice (two-way ANOVA: main effect of
genotype, F(2, 107) = 33.952, P<0.001; main effect of stress, F(1, 107) = 46.63, P<0.001; and
interaction between genotype and stress, F(2, 107) = 13.905, P<0.001).
Systemic dexamethasone challenge study to examine peripheral GR negative
feedback regulation of the HPA axis—To determine the optimal time point for the actions
of dexamethasone, a time course of effect of dexamethasone on suppression of ACTH and
corticosterone secretion was conducted in normal C57/B6 male mice. As shown in Fig. 8, the
basal corticosterone levels (saline injected mice) were significantly altered between 11:00am
– 3:00pm o’clock (2–6 hours after the injection, one-way ANOVA: F(1,10)=8.26, P < 0.05).
Dexamethasone reduced ACTH secretion one hour after the injection. The peak effect of
dexamethasone on ACTH secretion was observed 2 hours after the injection. The ACTH
concentration returned to normal four hours after the injection (Fig. 8, One-way ANOVA:
F(3,20)=5.13, P < 0.05). Corticosterone concentrations were reduced two hours after the
injection and peaked 4 hours after the injection of dexamethasone. The corticosterone
concentration returned to near normal 6 hours after the dexamethasone injection (Fig. 8, One-
way ANOVA: F(3,20)=9.84, P < 0.05). Therefore, we chose two hours as the time point for the
dexamethasone challenge test in SERT knockout mice.
Consistent with our previous observation (Li et al. 1999), the basal corticosterone levels in
SERT knockout mice were reduced in a genotype-dependent manner (Fig. 9). The
dexamethasone injection (20 μg/kg, ip) significantly reduced plasma corticosterone
concentrations in SERT +/+ and +/− mice comparing to the saline-treated mice. However, the
dexamethasone-induced suppression of corticosterone secretion was blunted in SERT−/− mice
(Fig. 9, two-way ANOVA: main effect of genotype, F(2, 25) = 2.598, P=0.0944; main effect of
dexamethasone, F(1, 25) = 27.713, P<0.001; and interaction between genotype and stress,
F(2, 25) = 7.545, P < 0.05).
Discussion
In the present studies, we determined the function and expression of several components of
the HPA axis and its negative feedback regulation in SERT knockout mice under basal and
stressed conditions. As summarized in Table 2, our results demonstrated that the HPA axis in
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SERT +/− and −/− mice is impaired. The overall basal activity of the HPA axis in the SERT
knockout mice was reduced, as demonstrated by the decreased CRF expression (Fig 1) and
low basal plasma corticosterone concentrations (Li et al. 1999;Lanfumey et al. 2000) (Fig 9).
The reduction of CRF may induce an up-regulation of CRF type 1 receptor (CRF R1), resulting
in an increase in the function and the density of CRF R1 in the pituitary of SERT −/− mice.
However, the reduced CRF expression did not increase, but indeed, reduced CRF R1 in the
pituitary of SERT+/− mice. These data suggest that the CRF R1 is differentially regulated
between SERT+/− and −/− mice. Under stressed conditions, the HPA axis in SERT +/−and −/
− mice is super-activated, consistent with our previous reports that minor stress, such as saline
injection, produces a significant increase of ACTH release in SERT +/−and −/− mice (Fig 2)
(Li et al. 2004;Li et al. 1999). The increased sensitivity to stress may be due to a reduction in
the glucocorticoid receptor-mediated feedback regulation. GR expression was significantly
reduced in all three organs of the HPA axis (the hypothalamus, pituitary and adrenal cortex)
of SERT+/− and −/− mice. These results support our hypothesis that the HPA axis and its
feedback regulation are impaired in SERT +/− and −/− mice, which could account for the
increased sensitivity to stress in these mice.
An elevated plus maze (EPM) was used as a stressor in the present study. We have previously
found that minor stress, such as handling and saline injection, increases ACTH secretion in
SERT+/− and −/− mice relative to SERT+/+ mice (Li et al. 1999). However, handling and
saline injection are not standard stressors. Tjurmina et al did not observe the differences in
ACTH response to restraint stress between the SERT knockout mice and their SERT normal
littermates (Tjurmina et al. 2004), which could be due to the fact that restraint stress produced
a maximal ACTH response in all three genotypes. Therefore, it is necessary to find a stressor
that can distinguish the stress response between SERT+/+ mice and SERT knockout mice.
EPM is a test for anxiety-like behavior, which tests the fear of the height and novelty (Rodgers
et al. 1997). Thus, EPM is a psychological stressor, a “stimuli which threaten the individual’s
current or anticipated state” (Dayas et al. 2001). We have found that the ACTH response to
EPM was more extensive in SERT+/− and −/− mice than that in SERT+/+ mice (Li 2006).
Therefore, EPM is an ideal stressor for the studies on increased sensitivity to stress in SERT
knockout mice. Since the anxiety-like behaviors of SERT knockout mice examined by EPM
have been reported by Holmes et al (Holmes et al. 2003b; Holmes et al. 2003c), we only used
EPM as a stressor in the present study.
Our present results showed that under non-stressed conditions CRF mRNA levels in the PVN
of SERT+/− and −/− mice were significantly lower than that of SERT+/+ mice. The data
suggest that the increased sensitivity of HPA axis to stress is not due to increase in the CRF
expression, but may result from the increase in the CRF release. However, further studies are
required to determine the mechanisms underlying the reduction of CRF mRNA in basal
conditions. One possible explanation is that the reduction of CRF mRNA in the PVN of SERT
knockout mice could be an adaptive change resulting from increased sensitivity of the HPA
axis to stress. Studies have found that chronic stress reduced CRF mRNA levels in the PVN
(Lightman 2008). Although activation of GR is the major inhibitor for the activity of the HPA
axis, the reduced GR expression in the SERT+/− and −/− mice (Fig. 6 and 7) suggests that
other transcription factors may be more important in suppression of CRF expression. This is
consistent with evidence that manipulating corticosterone levels does not affect the kinetics of
stress-induced alterations in the phosphorylation of the transcription factor cAMP-response
element-binding protein (CREB) in CRF neurons in 5 –15 min after stress, which is paralleled
with increases in the CRF heteronuclear RNA (hnRNA) (Kovacs and Sawchenko 1996; Kovacs
et al. 2000). An alternative mechanism could be that the reduction in the CRF mRNA
expression in SERT knockout mice is mediated by epigenetic regulation during early
development of these animals. It will be interesting to study the mechanisms underlying the
regulation of CRF expression in the PVN of SERT knockout mice.
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Studies have found that the resting level of corticosterone in SERT−/− mice is reduced, whereas
the resting level of ACTH remains normal (Li et al. 1999; Lanfumey et al. 2000). Consistent
with these results, we observed a significant reduction in the corticosterone concentration 2
hours after a saline injection in SERT −/− mice (i.e resting level, Fig 9). On the other hand, as
a results of an increase in the sensitivity to stress, minor stressors, such as handling and saline
injection, increased HPA axis activity in SERT knockout mice (Li et al. 1999). The increased
sensitivity of the HPA axis to stress could account for the increased corticosterone levels 30
minutes after the saline injection in SERT−/− mice (Fig. 2). Interestingly, in SERT+/− mice,
minor stress (such as a saline injection) induces a significant increase in the ACTH response,
whereas the increase in the corticosterone responses to stress is not as remarkable as the ACTH
responses (fig.2). These observations suggest dissociation in ACTH-induced increase of
corticosterone secretion in SERT knockout mice. Dissociation between ACTH and
corticosterone secretions has been reported in both physiological and pathological conditions,
which could be due to the dysregulation of adrenal cortex (Ahrens et al. 2008; Bornstein et al.
2008). For example, children of low-income women with maternal depressive symptoms have
a lower basal cortisol level and a blunted stress response (Fernald et al. 2008). Depressive
symptoms in elderly are associated to hypo- or hyper-cortisol levels (Penninx et al. 2007).
Therefore, the dissociation between ACTH and corticosterone secretions in SERT knockout
mice could be related to the increased sensitivity of the HPA axis to stress and altered behaviors.
However, the mechanism underlying the dissociation is still unknown.
The present results demonstrate that the basal GR expression in all three organs of the HPA
axis system are reduced in SERT+/− and −/− mice relative to SERT +/+ mice. The reductions
of GR in the hypothalamus are to a similar levels in SERT+/− and −/−mice. However, in the
pituitary and adrenal cortex, the reduction of GR mRNA is more extensive in SERT−/− mice
than that in SERT+/− mice. Differences between SERT+/−and −/− mice are further confirmed
by the dexamethasone challenge test. Dexamethasone is a GR agonist and does not cross blood
brain barrier. Also, GR in the adrenal cortex has the most direct effect on the inhibition of
corticosterone secretion. Therefore, the effect of dexamethasone on the reduction of
corticosterone secretion mainly measures the function of GR in the adrenal cortex. In the
present study, we observed a blunted corticosterone response to dexamethasone in SERT−/−
mice, but an almost normal response in SERT+/− mice. Considering about 30–40% reduction
of the GR mRNA in the adrenal cortex of SERT+/− mice, these results suggest that in the
adrenal cortex and pituitary there is receptor reserve. It is interesting that the alterations in the
HPA axis observed in the SERT knockout mice are similar with those in transgenic mice that
express GR antisense and have a 50% reduction of GR (Dijkstra et al. 1998). Both transgenic
mice and SERT knockout mice showed decreased basal CRF mRNA and basal corticosterone
levels (Dijkstra et al. 1998; Li et al. 1999; Lanfumey et al. 2000). This similarity suggests that
the alterations in the HPA axis in SERT knockout mice could result from the reduction of GR
expression. However, it does not explain why the decrease of the GR expression produces a
reduction in the basal level of the HPA axis. Besides GR in the hypothalamus, pituitary and
adrenal cortex, two corticoid receptors, MR and GR, in the hippocampus also play an important
role in regulating the HPA axis activity. However, since the present manuscript is focused on
alterations in the HPA axis, we will not further discuss the possible impact of these receptors
on alterations of the HPA axis.
In the hypothalamus, basal levels of both GR mRNA and protein are significantly reduced in
SERT+/− and −/− mice (Fig 5 and 6) relative to SERT+/+ mice, suggesting that the reduction
of GR in the PVN of SERT knockout mice may be mediated by an alteration at the
transcriptional level. However, the mechanisms underlying the reduction of the GR expression
in SERT knockout mice are still unknown. Evidence has demonstrated that the transcription
of GR can be epigenetically programmed by early environment (Szyf et al. 2005;Weaver et al.
2004;Weaver et al. 2002;Weaver et al. 2005;Weaver et al. 2007). For example, alterations in
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the maternal care can alter the methylation status of GR promoter and change GR expression
in adulthood (Weaver et al. 2004). One can expect that increased 5-HT concentrations during
early life of SERT knockout mice may cause epigenetic alterations that affect GR expression
later in life. Currently, no data is available regarding the regulation of GR expression in the
PVN of mice. It will be interesting to investigate the mechanisms that mediate the reduction
of GR expression in the hypothalamus of SERT knockout mice.
As a commonly accepted concept, transcriptional regulation in the brain usually takes hours.
Most studies observe alterations in mRNA levels more than 30 minutes after initiation of stress.
No data are available regarding transcriptional regulation of the HPA axis elements
immediately after 5 min of stress. As expected, our results showed that stress with EPM for 5
minutes did not alter the levels of GR mRNA in the PVN of SERT+/+ mice (Fig 6). However,
the GR mRNAs levels in the pituitary and adrenal cortex were altered by stress for only 5 min
in SERT +/+ mice (Fig. 7). Similarly, after stress for 5 min, expression of CRF R1 is increased
in the pituitary and adrenal cortex of SERT knockout mice (Fig 4). Since we have carefully
controlled animal housing and experimental conditions, it is unlikely that the alterations
observed were due to stimulation by additional stressors. Because the stress-induced alterations
mainly occurred in the pituitary and adrenal cortex, these data suggest that the regulation of
GR and CRF R1 expression in the pituitary and adrenal cortex may be more sensitive than that
in the brain. Currently, little data is available regarding the regulation of GR and CRF R1
expression in the pituitary and adrenal cortex during acute stress within 30 minutes. However,
several studies demonstrated that the CRF R1 in the pituitary is more sensitive to CRF or
corticosterone injections or longer stress (Aguilera et al. 1997;Aguilera et al.
2001;Nikodemova et al. 2002;Rabadan-Diehl et al. 1996;Rabadan-Diehl et al. 1997;Luo et al.
1995). For example, a transient reduction of CRF R1 mRNA in the pituitary was detected 2
hours after injection with dexamethasone (Luo et al. 1995). Consistent with this finding, we
have also observed that stress with EPM for 5 minutes produced a reduction of CRF R1 mRNA
in the pituitary of SERT knockout mice. Thus, it is possible that stress-induced decreases in
CRF R1 expression in the pituitary are a transient response induced by the increased CRF
secretion. However, future studies are required to understand the rapid alteration of gene-
expression in the pituitary and adrenal gland.
Several behavioral, cellular and molecular alterations have been observed in SERT −/− mice,
such as increased anxiety-like behaviors, reduced aggression, reduced 5-HT1A receptors and
increased 5-HT2C receptors (Holmes et al. 2003c; Murphy et al. 1999; Li 2006). However,
most of these alterations were not statistically significant between SERT+/+ and SERT+/−
mice. The most remarkable change in SERT +/− mice is the increase in sensitivity to stress.
This is specifically interesting because it is similar to human individuals with lower SERT
expression genotypes, who have anxiety-related personality traits and increased sensitivity to
stress. In the present studies, we demonstrated that the alterations of the CRF and GR in the
PVN of SERT +/− mice are similar with that in SERT −/− mice, which is consistent with the
increased sensitivity to stress in both SERT+/− and −/− mice. However, in the pituitary and
adrenal cortex, the alterations in the SERT +/− mice are not always similar with that in the
SERT−/− mice. For example, the density of CRF R1 in the pituitary is increased in the SERT
−/− mice, but reduced in SERT +/− mice (Fig. 3). This is consistent with the results observed
from CRF challenge study, in which SERT−/−, but not SERT+/−, mice showed an increased
response to CRF injection (Fig. 2). On the other hand, although the expression of GR was
reduced in the pituitary and adrenal cortex of both SERT+/− and −/− mice, the SERT+/− mice
showed a normal response to dexamathasone challenge (Fig. 9). Furthermore, the basal level
of plasma corticosterone is reduced in SERT−/− mice, but not in SERT+/− mice. These data
suggest that the impairment of the HPA axis in SERT+/− and −/− mice may not be mediated
by similar mechanisms. Since the phenotypes of SERT+/− mice are closer to humans with
lower SERT expression genotype, studying in the mechanisms mediating the increased HPA
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axis sensitivity to stress in SERT+/− mice will provide an important insight for us to
understanding the etiology of affective disorders and developing better therapeutic approaches
for these diseases.
In summary, the present studies demonstrate, for the first time, that the HPA axis and its
feedback regulation are impaired in SERT +/− and −/− mice, which may account for the
increased sensitivity to stress in these mice. These data are important because they provide
insight for the hypersensitivity to stress observed in human individuals with lower SERT
expression genotype. The alterations of the HPA axis and its feedback regulation in SERT
knockout mice could occur during development because 5-HT functions as a neurotrophic
factor during development. One can expect that alterations in extracellular 5-HT concentrations
will cause numerous changes in the neuronal development. Another possible cause for
alterations in the HPA axis is that SERT knockout mice are more anxious due to the alterations
of 5-HT receptors (Holmes et al. 2003d). Long-term stress could cause changes in the HPA
axis in these mice. Understanding these mechanisms will have an important impact on
understanding the etiology of affective disorders, especially for the individuals with lower
SERT expression genotypes or individuals whose SERT function is altered during development
due to other circumstances, such as administration of selective serotonin reuptake inhibitors
(SSRIs) during pregnancy and maternal stress.
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Fig. 1. Reduction of the CRF mRNA in the PVN of SERT knockout mice under non-stressed
condition
A: Example of autoradiography of the CRF mRNA in situ hybridization in the paraventricular
nucleus (PVN); B: Reduction of the CRF mRNA in the PVN of SERT knockout mice examined
by in situ hybridization. C: Reduction of the CRF mRNA in the hypothalamus of SERT
knockout mice determined by quantitative RT-PCR. The data were represented as mean ± SEM
(n = 4–5 mice). * Significantly different from SERT+/+ mice, P<0.05 (Student-Newman-Keuls
post hoc test).
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Fig. 2. Hormonal responses to systemic injection of the CRF in SERT knockout mice
SERT knockout mice were injected with CRF (20μg/kg, sc) or saline 30 min before
decapitation. The data were represented as mean ± SEM (n = 5–7 mice). Top panel: ACTH
response to CRF; Bottom panel: Corticosterone response to CRF. *: Significantly different
from saline group of same genotype mice, P<0.05. #: significantly different from SERT+/+
mice with same stress treatment P<0.05 (Student-Newman-Keuls post hoc test).
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125I-sauvagine binding for the density of CRF R1 in pituitary of SERT knockout mice.
A: Example of 125I-sauvagine binding in the pituitary. Arrows indicate the anterior pituitary
regions (AP); B: Alteration in the density of CRF R1 in the pituitary of SERT knockout mice.
The data were represented as mean ± SEM (n = 5–7, mice). * Significantly different from basal
level of same genotype mice P<0.05. #: significantly different from SERT+/+ mice with same
stress treatment, P<0.05 (Student-Newman-Keuls post hoc test).
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Fig. 4. CRF R1 mRNA in the pituitary of SERT knockout mice
A: Example of autoradiography of CRF R1 mRNA in situ hybridization in the pituitary. Each
picture contains seven pituitaries. The regions measured were same as shown in Fig. 3; B:
Alteration of the CRF R1 mRNA in the pituitary of SERT knockout mice during basal and
stressed conditions. The data was represented as mean ± SEM (n=5–7, mice). * Significantly
different from basal level of same genotype mice, P<0.05. #: significantly different from SERT
+/+ mice with same stress treatment P<0.05 (Student-Newman-Keuls post hoc test).
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Fig.5. Alteration of the GR level in the hypothalamus of SERT knockout mice under non-stressed
and stressed conditions
A: Example of immunoblot of the GR in the hypothalamic subcellular extractions. N: Non-
stressed; S: Stressed; B: The GR protein levels in the non-nuclear (top, cytosol/membrane) and
nuclear (bottom) fractions of the hypothalamus of SERT knockout mice were examined using
immunoblots. The data were calculated as percent of non-stressed SERT+/+ mice and
presented as mean ± SEM (n = 5–6, mice). * Significantly different from non-stressed mice
with same genotype, P<0.05. #: significantly different from SERT+/+ mice with same stress
treatment, P<0.05 (Student-Newman-Keuls post hoc test).
Jiang et al. Page 21













Fig 6. Alterations of GR mRNA in the PVN of SERT knockout mice under non-stressed and stressed
conditions
A: Example of autoradiography of in situ hybridization for GR mRNA in the PVN; B:
Alteration in the GR mRNA in the PVN of SERT knockout mice. The data were represented
as mean ± SEM (n = 5–6). #: significantly different from SERT+/+ mice with same stress
treatment P<0.05 (Student-Newman-Keuls post hoc test).
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Fig 7. Alterations of GR mRNA in the pituitary and adrenal cortex of SERT knockout mice under
non-stressed and stressed conditions
A: Example of autoradiography of in situ hybridization for GR mRNA in the pituitary and
adrenal cortex. Arrow indicates the adrenal cortex. Each picture contained six pituitaries or
adrenal glands. B: Alteration in the GR mRNA in the pituitary of SERT knockout mice. C:
Alteration in the GR mRNA in the adrenal cortex of SERT knockout mice. The data were
represented as mean ± SEM (n = 5–7). * Significantly different from non-stressed mice with
same genotype, P<0.05. #: significantly different from SERT+/+ mice with same stress
treatment, P<0.05 (Student-Newman-Keuls post hoc test).
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Fig 8. Time course of the effect of dexamethasone on ACTH and corticosterone
Mice (C57/B6) were injected with dexamethasone (20 μg/kg, ip) at 9:00am and discapited 1,
2, 4 and 6 hours after the injection. Trunk blood was collected for determination of plasma
ACTH and corticosterone levels. The data were represent as mean ± SEM (n = 6–7 mice). *:
Significant difference from 6 hours after same injection, P<0.05. #: Significant difference from
saline injected group at same time-point, P<0.05 (Student-Newman-Keuls post hoc test).
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Fig 9. Systemic dexamethasone challenge study in SERT knockout mice
Dexamethasone or saline were injected into SERT knockout mice. The mice were decapitated
2 hours after the injection. The data were represent as Mean ± SEM (n = 6–8 mice). *
Significantly different from saline injected same genotype mice P<0.05. #: significantly
different from SERT+/+ mice with same treatment P<0.05 (Student-Newman-Keuls post hoc
test).
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Table 1
Design of ribo-probes for in situ hybridization
mRNA cDNA fragment Accession No. Primers References
CRF mRNA 118–692 NM_205769 5′-CTC TGC AGA GGC
AGC AGT G-3′
5′-GCT AAC TGC TCT
GCC CGG-3′
(Schmidt et al., 2003)
GR mRAN 1203–1674 NM-008173 5′-CAC CCC ACC AAT
TCC TGT TGGTTC-3′
5′-CAG AAG TGT CTT
GTG AGA CTC C-3′
(Schmidt et al.,2003)
CRF R1 mRNA 672–1277 NM-007762 5′-CAC CGC TTT CAT CCT
GCG CAA C-3′
5′-GAA CAC AGA CAC
GAA GAA GCC-3′
(Luo et al., 1995)
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